Emerging therapies for diabetic kidney disease: beyond SGLT2 inhibitors
This review summarizes contemporary guideline-directed therapy for DKD and examines emerging therapeutic strategies targeting complementary pathways implicated in kidney disease progression, which include novel incretin-based therapies, aldosterone synthase inhibitors, endothelin receptor antagonists, soluble guanylate...